This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Drug Names(s): EDC-9, EDC 9
EDC-9 is an antibody-drug conjugate targeting CD20, under development by Centrose using its proprietary Extracellular Drug Conjugate (EDC) technology.
Additional information available to subscribers only: